MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$71,870K
Marketable securities
$66,512K
Prepaid expenses and
other current assets
$6,099K
Restricted cash
$4,195K
Property and equipment,
at cost
$81,661K
Total current assets
$148,676K
Goodwill
$140,627K
Intangible asset
$59,195K
Operating lease
right-of-use assets
$38,313K
Property and equipment,
net
$26,906K
Other non-current
assets
$3,173K
Less accumulated
depreciation
$54,755K
Total assets
$416,890K
Total liabilities and
stockholders' equity
$416,890K
Total liabilities
$256,006K
Total stockholders'
equity
$160,884K
Accumulated deficit
-$1,849,016K
Contingent consideration,
net of current...
$83,518K
Total current
liabilities
$78,726K
Operating lease
liabilities, net of current...
$63,924K
Success payment
liabilities
$19,238K
Other non-current
liabilities
$10,600K
Additional paid-in capital
$2,009,845K
Accumulated other
comprehensive income
$28K
Common stock, 0.0001
par value 750,000...
$27K
Contingent consideration
$40,200K
Operating lease
liabilities
$14,938K
Accrued compensation
$13,240K
Accrued expenses and
other current...
$8,679K
Accounts payable
$1,669K
Back
Back
Balance Sheet
source: myfinsight.com
Sana Biotechnology, Inc. (SANA)
Sana Biotechnology, Inc. (SANA)